全球異噁唑啉市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計異噁唑啉市場將從 2025 年的 55.7 億美元成長到 2034 年的 120.8 億美元，2026 年至 2034 年的複合年成長率為 8.98%。

由於異噁唑啉類藥物在獸醫學領域，尤其是在伴侶動物寄生蟲防治方面應用廣泛，全球異噁唑啉市場正穩定成長。異噁唑啉類藥物常用於寵物跳蚤和蜱蟲防治，具有持久的保護作用和高效率的防治效果。寵物數量的不斷成長以及人們對動物健康意識的提高是全球對這些產品需求的主要促進因素。

推動市場成長的關鍵因素包括寵物「人性化」趨勢、寵物醫療保健支出增加以及動物用藥品的進步。製藥公司正在研發創新的口服和外用製劑，以提供對寄生蟲的長期保護。此外，新興市場獸醫服務的擴展以及寵物護理產品取得途徑的改善也進一步促進了市場成長。

異噁唑啉市場預計未來將保持強勁成長，這主要得益於持續的產品創新和不斷擴大的應用領域。針對多種寄生蟲的聯合治療的研發將提升產品的吸引力。隨著全球寵物飼養量的持續成長，尤其是在都市區，對高效且便利的寄生蟲防治方案的需求將保持旺盛。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球異噁唑啉市場：依產品類型分類

• 市場分析、洞察與預測
• 弗魯拉拉納爾
• 阿福佐蘭
• 薩洛拉
• 烤餅燈籠

第5章：全球異噁唑啉市場：依寵物類型分類

• 市場分析、洞察與預測
• 狗
• 貓

第6章 全球異噁唑啉市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Sigma Aldrich Inc
  • Carbanio
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc
  • Merck Animal Health Inc
  • Zoetis Inc
  • Virbac SA
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA

The Isoxazoline Market size is expected to reach USD 12.08 Billion in 2034 from USD 5.57 Billion (2025) growing at a CAGR of 8.98% during 2026-2034.

The global isoxazoline market is growing steadily due to its widespread application in veterinary medicine, particularly for controlling parasites in companion animals. Isoxazolines are commonly used in flea and tick treatments for pets, offering long-lasting protection and high efficacy. Increasing pet ownership and rising awareness about animal health are key factors driving the demand for these products globally.

Key drivers include the growing trend of pet humanization, increased spending on pet healthcare, and advancements in veterinary pharmaceuticals. Pharmaceutical companies are developing innovative oral and topical formulations that provide extended protection against parasites. Additionally, the expansion of veterinary services and improved access to pet care products in emerging markets are further boosting market growth.

Looking forward, the isoxazoline market is expected to witness strong growth with continuous product innovation and expanding applications. The development of combination treatments targeting multiple parasites will enhance product appeal. As pet adoption continues to rise globally, especially in urban areas, the demand for effective and convenient parasite control solutions will remain robust.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Fluralaner
• Afoxolaner
• Sarolaner
• Lotilaner

By Pet Type

• Dog
• Cat

COMPANIES PROFILED

• Sigma Aldrich Inc, Carbanio, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc, Merck Animal Health Inc, Zoetis Inc, Virbac SA, CevaSant Animale, Dechra Pharmaceuticals PLC, Vetoquinol SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ISOXAZOLINE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Fluralaner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Afoxolaner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sarolaner Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Lotilaner Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ISOXAZOLINE MARKET: BY PET TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Pet Type
• 5.2. Dog Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cat Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ISOXAZOLINE MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By Pet Type
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By Pet Type
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By Pet Type
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By Pet Type
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By Pet Type
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ISOXAZOLINE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Sigma Aldrich Inc
  • 8.2.2 Carbanio
  • 8.2.3 Boehringer Ingelheim International GmbH
  • 8.2.4 Elanco Animal Health Inc
  • 8.2.5 Merck Animal Health Inc
  • 8.2.6 Zoetis Inc
  • 8.2.7 Virbac SA
  • 8.2.8 Ceva Sante Animale
  • 8.2.9 Dechra Pharmaceuticals PLC
  • 8.2.10 Vetoquinol SA